The risk of developing cancer does not continue to rise indefinitely with age, as commonly believed. Instead, data reveals a notable decline in cancer incidence among people in their 90s. This unexpected pattern, known as the longevity paradox, has prompted scientists to explore underlying biological mechanisms. Researchers are examining cellular repair processes, genetic stability, and immune system adaptations in the oldest individuals to understand how they naturally resist cancer. These insights could unlock new approaches to cancer prevention and extend healthy aging.
Hosted by Hank Green, this discussion highlights recent advances in aging biology and oncology. By studying populations that live beyond 90, scientists aim to identify protective traits that could be replicated in broader medical strategies. The findings may lead to therapies that enhance the body’s innate defenses against disease. Understanding how extreme longevity correlates with reduced cancer risk offers a promising path toward improving health outcomes across all age groups.